L-arginine-NO pathway and CNS oxygen toxicity

Area of Science:

• Neuroscience
• Physiology
• Pharmacology

Background:

• Hyperoxia-induced seizures are a significant concern in hyperbaric oxygen therapy.
• The role of the L-arginine-nitric oxide (NO) pathway in central nervous system oxygen toxicity remains incompletely understood.

Purpose of the Study:

• To investigate the involvement of the L-arginine-NO pathway in the pathogenesis of hyperoxia-induced seizures.
• To elucidate the regulatory mechanisms of NO in CNS oxygen toxicity.

Main Methods:

• Utilized rats with chronic cortical electrodes exposed to hyperbaric oxygen (0.5 MPa O2) and a hypercapnic-hyperoxic mixture.
• Administered systemic (L-NAME) and cerebral-specific (7-nitroindazole) nitric oxide synthase inhibitors.
• Administered NO donor (S-nitroso-N-acetylpenicillamine) and NO precursor (L-arginine) to modulate NO levels.

Main Results:

• Both nitric oxide synthase inhibitors (L-NAME, 7-nitroindazole) significantly prolonged the latent period to seizure onset under hyperbaric conditions.
• The NO donor S-nitroso-N-acetylpenicillamine significantly shortened the latent period.
• L-arginine administration significantly prolonged the latent period to seizure onset.

Conclusions:

• The L-arginine-NO pathway plays a crucial role in the pathophysiology of hyperoxia-induced seizures.
• Modulation of NO levels through various agents impacts CNS oxygen toxicity, suggesting complex regulatory mechanisms.